Creative Doctors ๐Ÿ–ค
4.19K subscribers
968 photos
27 videos
358 files
458 links
Med notes ๐ŸŽถ
Download Telegram
ACS guidelines 2023.pdf
11.4 MB
2023 ESC GUIDLINES FOR THE MANAGEMENT OF acute Coronary Syndrome
Today 25/8/2023
โค5
Creative Doctors ๐Ÿ–ค
Photo
ุงู„ุฌูˆุงุจ ู…ู† ู…ุญุงุถุฑุงุชู†ุง ุงู„ู‚ุงุฏู…ู‡ ููŠ ูƒูˆุฑุณ ุงู„ endocrine ุŒ ุงู†ุดุงุก ุงู„ู„ู‡ ูŠูˆู… ูกู  ุจู„ุดู‡ุฑ ู…ุน ุจู‚ูŠุฉ ุงู„ูƒูˆุฑุณุงุช ู†ุนู„ู† ุนู†ู‡ุง..
โค6
Highlights of the first day of the 2023 ESC-congres
1- SGLT2 inhibitors are recommended as class I in HF mrEF and HFpEF (dapagliflozin and empagliflozin)
2- there is no change in the strategies of antithrombotic treatment in patients with ACS :
Aspirin + P2Y12 unhibtirs for 12 months flooded by aspirin alone for life long (class I).
3- Surgery is recommended for early Prosthetic valve endocarditis (less than 6 months) with new valve replacement and complete debridement (class IC)
4- ACS management in cancer patients:
Invasive strategy if the life expectancy >6 months
Conservative management if poor prognosis
Antithrombotic therapy according to platelet count
5- SGLT2 inhibitors are recommended as first line treatment ( class I) in type 2 diabetic patients with established ASCVD (to reduce CV risk independent of glucose control , in type2 diabetic patients with HF(to reduce HF hospitalizations ), and in type 2 diabetic patients with CKD (to reduce CV risk and kidney failure risk).
6- Colchicine is the first anti-inflammatory agent (0.5 mg once daily) approved by US FDA and health Canada to reduced the risk of atherothrombotic events in patients with established ASCVD.
7-Colchicine does not significantly reduce perioperative Afib or myocardial injury after non-cardiac surgery (MINS) in patients undergoing major non-cardiac thoracic surgery.
8- Semaglutide (which belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists) improves heart failure-related symptoms and physical function and results in greater weight loss compared with placebo in patients with HFpEF and obesity (STEP-HFpEF trial)
9- NOACs are finally approved for the treatment of LV thrombus as a complication of ACS( class IIa).
10- DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants
11- complete revascularization should be done either during the index procedure or within 45 days in patients with STEMI (class I).
12- face to an out-hospital cardiac arrest, Primary PCI is recommended as class I when the ECG shows ST segment elevation and class IIIA when the ECG is normal (no routine immediate coronary angiogram).
โค2
ูŠุฑุญู…ูƒู… ุงู„ู„ู‡ ุฑูƒุฒูˆุง ุนู„ู‰ ู…ูˆุถูˆุน NSTACS with high risk features
ุงุฑุฌูˆูƒู…ู…ู…ู… ูŠุนู†ูŠ ู‡ุฐุง ุชุฑูƒุถ ุจูŠู‡ ู„ู„ PCI ุญุงู„ู‡ ุญุงู„ ุงุจูˆ STEMI ุŒ ุฑุฌุงุกุงู‹ ุฑุฌุงุกุงู‹ ุŒ ูˆุงู„ู„ู‡ ู‡ูˆุงูŠ ูƒูŠุณุงุช NSTACS ู…ุง ูŠุชู… ุงู„ุชุนุงู…ู„ ุงู„ุตุญูŠุญ ูˆูŠุงู‡ู… ..

high risk features
Heamodynamic instability
life threatening arrhythmia
refractory ischemiac pain
AHF
mechanical complication
STEMI equivalents
GRACE score >140
dynamic ST change
dynamic troponin change
โค10
Creative Doctors ๐Ÿ–ค
ูŠุฑุญู…ูƒู… ุงู„ู„ู‡ ุฑูƒุฒูˆุง ุนู„ู‰ ู…ูˆุถูˆุน NSTACS with high risk features ุงุฑุฌูˆูƒู…ู…ู…ู… ูŠุนู†ูŠ ู‡ุฐุง ุชุฑูƒุถ ุจูŠู‡ ู„ู„ PCI ุญุงู„ู‡ ุญุงู„ ุงุจูˆ STEMI ุŒ ุฑุฌุงุกุงู‹ ุฑุฌุงุกุงู‹ ุŒ ูˆุงู„ู„ู‡ ู‡ูˆุงูŠ ูƒูŠุณุงุช NSTACS ู…ุง ูŠุชู… ุงู„ุชุนุงู…ู„ ุงู„ุตุญูŠุญ ูˆูŠุงู‡ู… .. high risk features Heamodynamic instability life threatening arrhythmiaโ€ฆ
ูˆุงู„ู„ู‡ ุงู„ุนุธูŠู… ุงู„ู…ุฑูŠุถ ูŠุจุชู„ูŠ ุนู„ู‰ ุนู…ุฑู‡ ู…ู† ูŠุฌูŠ ุจ NSTACS
ูŠุนู†ูŠ ู„ูˆ ูŠุฌูŠ ุจ STEMI ุงุญุณู„ู‡ ูˆู„ุง ู‡ู„ุทู„ุงุจู‡ ุงู„ูŠ ุชุตูŠุฑ ุจู„ู…ุณุชุดูู‰ ู…ู† ูˆุฑุงู‡ ูˆูƒู„ู…ู† ูŠู‚ุฑุฑู„ู‡ ุดูŠ ..
ุงู„ู…ุดูƒู„ู‡ ู‡ู„ุฌุฒุฆูŠู‡ ูƒู„ุด ูƒุฑุชูƒุงู„
โค2
ู…ูˆู‚ู ุญู‚ูŠู‚ูŠ ุตุงุฑ ูˆูŠ ุจูŠุจุชูŠ ุนู…ุฑู‡ุง 70 ุงู„ู„ู‡ ูŠุทูˆู„ ุจุนู…ุฑู‡ุง ุงู†ูŠ ุจู„ุจุตุฑู‡ ุจู„ุฏูˆุงู… ู…ุงุนุฑู ุดู†ูˆ ุงู„ุณุงู„ูู‡ ุŒ
ุจูŠุจุชูŠ ุนุฏู‡ุง
breast Cancer
DM
HTN
ุตุงุฑ ุนุฏู‡ุง ุงู„ู… ุจุตุฏุฑู‡ุง ูˆุชู‚ูŠุฃุช
Typical ACS
ุงูˆู„ ู…ุฑุงุญุช ู„ู„ู…ุณุชุดูู‰ ุฏุฎู„ุช ุจVT
ูˆุตุงุฑุช unstable ูˆุฑุฌุนุช sinus ูˆุญุฏู‡ุง ุŒ negative troponin and non specific ecg change

ู„ู‡ู†ุง ุงู„ Heart score ุตุงุฑุช ุงู„ู ู…ูˆ 8 ุŒ ุตุญ ุงู„ูƒู„ุงู… ู„ูˆ ุงู†ูŠ ู…ุชูˆู‡ู… ุŸุŸ
ุชุฎูŠู„ูˆุง ุงู„ next step ?
ุณูˆูˆู„ู‡ู‡ discharge ูˆุชุฑุงุฌุนูŠู† ุงุฎุตุงุฆูŠ ุจุงุฌุฑ ุงู„ุนุตุฑ ุŒ ุนู„ู…ุง ุฏุฎู„ุช ุจAHF ู…ู†ุง ู„ู„ุนุตุฑ ูˆุฏูˆู‡ุง ู„ู„ู…ุณุชุดูู‰ ุณูˆูˆู„ู‡ู‡ pci ุฎุทูŠู‡ ูˆู‡ุณู‡ ู…ุชุงุฐูŠู‡ ูƒู„ุด ุตุงุฑุช chroinc
ูŠุนู†ูŠ ู‚ุตู‡ ู…ุฃุณุงูˆูŠู‡ ูˆุงู„ู„ู‡
ู„ูˆ ุตุงูŠุฑู‡ STEMI ุงุญุณุณู„ู‡ุง ุฌุงู† ุงู„ุฏูƒุชูˆุฑ ุงู„ุนุจู‚ุฑูŠ ุงู„ูˆุงูƒู ูŠู…ูƒู† ูŠุนุฑู ุงู†ูˆ ุงุจูˆ STEMI ู…ุจุงุดุฑู‡ pci ูˆูŠูˆุฏูŠู‡ุง
ุจุณ ู…ุตูŠุฑู‡ุง ูˆู‚ุฏุฑ ุงู„ู„ู‡ ุดู†ุณูˆูŠ
โค10
- NOACs are finally approved for the treatment of LV thrombus as a complication of ACS( class IIa).
โค2
Give me a Drug
can cause three types of jundice ( mixed jundice)
ูŠุนู†ูŠ ู…ู…ูƒู† ูŠุณูˆูŠ
heamolytic jundice
Hepatocelluar jundice
cholestatic jundice
ู…ู…ูƒู† ูŠุณูˆูŠู‡ู… ูƒู„ู‡ู… ุจู†ูุณ ุงู„ูˆู‚ุช??
โค4
ุงู†ูŠ ู…ุงุนุฑู ู„ูŠุด ุฏุงุฆู…ุง ุจู„ุดุฑูˆุญุงุช ุงูˆู„ ู…ุง ูŠุจุฏูˆู† ุจู„ ECG ูŠุจุฏูˆู† ุจู„ูˆุฑู‚ู‡ ูˆูŠูƒุนุฏ ูŠู‚ุณู…ู„ูƒ ู…ุฑุจุนุงุช ุตุบูŠุฑู‡ ูˆูƒุจูŠุฑู‡ ูˆุทูˆู„ ูˆุนุฑุถ ูˆู…ู† ุนุฏู‡ุง ุงู†ุช ุชูƒุฑู‡ ุงู„ุงูŠุณูŠุฌูŠ ูˆุงู„ุณุงุนู‡ ุงู„ุฏุฑุณุชู‡ุง ุจูŠู‡๐Ÿ˜‚ ู‡ุงูŠ ูˆุฑู‚ู‡ ุงู„ุงูŠุณูŠุฌูŠ ุดูˆููˆู‡ุง ุดูƒุฏ ุชุงูู‡ู‡ ุญุงู„ู‡ุง ุญุงู„ ูˆุญุฏู‡ ู‚ูŠุงุณ ู…ุซู„ ุงู„ููŠุชู‡ ูˆุงู„ tape measure
ูˆู‚ุณู…ูˆู‡ุง ู…ุฑุจุนุงุช ุตุบูŠุฑู‡ ูˆูƒุจูŠุฑู‡
ู†ูุณ ููƒุฑุฉ ุงู„ู…ุชุฑ ูˆุงู„ุณู†ุชูŠู…ุชุฑ ุŒ ูˆุงุญู†ู‡ ุงุตู„ุง ู…ู†ุนุชุฑู ุจุงู„ุงุฑู‚ุงู… ุงุญู†ู‡ ู†ุชุนุงู…ู„ ุจู„ู…ุฑุจุนุงุช ุŒ ุนูˆุฏ ู…ู† ูŠุตูŠุฑ ุนุฏู†ุง ุจุญุซ ุนู„ู…ูŠ ู†ูƒุชุจ ุจู„ู‚ูŠู… ุงู„ุฑู‚ู…ูŠู‡ ุงู…ุง ุจู„ุญูŠุงุฉ ุงู„ูˆุงู‚ุนูŠู‡ ู†ุชุนุงู…ู„ ุจู„ู…ุฑุจุนุงุช ุญุตุฑุงู‹
ูˆุงุฎูŠุฑุงู‹ ุฑุณู…ูŠุงู‹ ูƒู…ู„ู†ุง ุงู„ Normal
ู…ุดุงุนุฑ ู…ุชุถุงุฑุจู‡ ุญุงู„ูŠุงู‹ ู‡ุณู‡ ุนู†ุฏูŠ ุŒ ุงู„ู‚ุฑูŠุจูŠู† ุนู„ูŠู‡ ูŠุนุฑููˆู† ุดูƒุฏ ุชุนุจุงู† ุงู†ูŠ ู‡ู„ูุชุฑู‡ ู„ูƒู† ุชูˆููŠู‚ ุงู„ู„ู‡ ูˆุฑุญู…ุชู‡ ูˆุงู„ุฃุตุฑุงุฑ ูƒุฏุฑุช ุงุทู„ุน ุจู‡ู„ู†ุชูŠุฌู‡ ุงู„ูŠ ู…ูƒู†ุช ู…ุชูˆู‚ุนู‡ุง ุตุฑุงุญุฉ ุŒ ุงู„ุญู…ุฏุงู„ู„ู‡ ู…ุง ุฎูŠุจุช ุงู…ู„ูƒู… ุจูŠู‡ ุŒ ุชูƒุฏุฑูˆู† ุชุนุชุจุฑูˆู† ู‡ุฐุง ุงู„ุดุฑุญ ู…ุตุฏุฑ ุฃุณุงุณูŠ ูˆุชุนุชู…ุฏูˆู† ุนู„ูŠู‡ ุงุนุชู…ุงุฏ ูƒู„ูŠ ุŒ ุจู‚ุช ุจุณ chambrlien rules ุงู„ูŠ ู‡ูŠ ุจุณูŠุทู‡ ุฌุฏุงู‹ ุจุงุฌุฑ ุชู†ุฒู„
โค31
Creative Doctors ๐Ÿ–ค
https://youtu.be/3ka-zTja2xg?si=VfDX-aO4Ex6fNQft
ู‡ุงูŠ ุงู„ู…ุญุงุถุฑู‡ ุงูŠ ูˆุงุญุฏ ู…ูŠุฑูŠุฏ ูŠุดูˆู ุงู„ูƒูˆุฑุณ ูƒู„ู‡ ุฎู„ูŠุดูˆู ู‡ุงูŠ ุฑุฌุงุกุงู‹ ุŒ ู‡ุงูŠ ุงู„ู…ุญุงุถุฑู‡ ุฑุงุญ ุชู„ฺฏู‡ ุงู„ูŠ ุงู†ุช ุฏุงุฆู…ุง ู…ุถูŠุนู‡ ูˆู…ุง ุชุนุฑู ุฌูˆุงุจู‡ ุดู†ูˆ ุŒู‡ุงูŠ ุงู„ู…ุญุงุถุฑู‡ ุจูŠู‡ุง ุฌูˆุงุจ ู„ุณุคุงู„ ุงู†ุช ู…ุง ุชุฏุฑูŠ ุจูŠู‡ ู…ูˆุฌูˆุฏ ู‡ุงูŠ ุงู„ู…ุญุงุถุฑู‡ ุŒ ูฉูฅ ุจู„ู…ูŠู‡ ูˆุงู†ูŠ ูˆุงุซู‚ ู…ู† ูƒู„ุงู…ูŠ ูŠูƒุฑู‡ูˆู† ุงู„ุงูŠุณูŠุฌูŠ ู…ู† ูˆุฑุงู‡ู‡ ู„ุงู† ู‡ู… ูŠุฏูˆุฎูˆู† ุจูŠู‡ุง ุงุตู„ุงู‹ ูุฑุฌุงุกุงู‹ ู…ู‡ู…ุง ูƒุงู† ู…ุณุชูˆุงูƒ ุดูˆูู‡ุง
โค15๐Ÿ‘1
ู†ุตูŠุญุฉ ุจุนุฏ ู…ุง ูƒู…ู„ู†ุง ุงู„ู†ูˆุฑู…ุงู„ ูˆุงุฐุง ุงุญุฏ ูŠุฑูŠุฏ ูŠุจุฏูŠ ู…ู† ุงู„ุจุฏุงูŠู‡ ุงู„ุฃูุถู„ ุชุจุฏูŠ ุจูŠู‡ู† ูƒู„ู‡ู† ุฏูุนู‡ ูˆุญุฏู‡ ูŠุนู†ูŠ ู„ุชู‚ุฑู‡ ู…ุงุฏู‡ ุซุงู†ูŠู‡ ุบูŠุฑู‡ ุชุฑูƒุฒ ุจูŠู‡ ุจุณ ู‡ูˆ ุนู„ู…ุง ุชุฎู„ุตู‡ ูˆุทุจุนุงู‹ ุงู„ูŠ ุชู…ูŠุฒู†ุง ุจูŠ ู‡ูˆ ู‚ุตุฑ ุงู„ูˆู‚ุช ูŠุนู†ูŠ ุงุฐุง ุชุณุฑุน ุงู„ุตูˆุช 1.5 ุญูŠุตูŠุฑ ุงู„ normal ูƒู„ู‡ ุณุงุนุชูŠู† ุงูˆ ุงู‚ู„ ูˆุจู„ู…ู†ุงุณุจู‡ ู„ุงุฒู… ุชุณุฑุน 1.5 ุญุชู‰ ูŠุตูŠุฑ ุงู„ุตูˆุช ู…ุชูˆุงุฒู† ู„ุงู† ุงู†ูŠ ุจุทุฆุช ุตูˆุชูŠ ูˆุฑุงุนูŠุช ู‡ู„ุณุงู„ูู‡ ูˆูƒู„ ุงู„ุชูˆููŠู‚ ูŠุงุฑุจโค๏ธ
โค18๐Ÿ‘2๐Ÿ‘1๐Ÿฅฐ1
๐Ÿ”ฅ15โค12๐Ÿ‘2